Actively Recruiting
Feasibility and Acceptability of HCV Treatment in Pregnancy
Led by Washington University School of Medicine · Updated on 2025-12-29
50
Participants Needed
2
Research Sites
108 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Pregnant adults over the age of 18 who are seen in the Washington University obstetrics and gynecology, maternal fetal medicine or infectious diseases clinic or admitted to BJH with hepatitis C virus infection who have a history of past or current drug use Participant Duration: Approximately 1 year. Aims: Aim 1 - Evaluate adherence and treatment completion rates when glecaprevir-pibrentasvir is started during pregnancy for women who use drugs. Aim 2 - Evaluate patient experience with hepatitis C virus treatment during pregnancy.
CONDITIONS
Official Title
Feasibility and Acceptability of HCV Treatment in Pregnancy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients 18 years old or older
- Pregnant at the time of study intake
- Diagnosed with hepatitis C virus infection
- History of past or current drug use
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Barnes Jewish Hospital
St Louis, Missouri, United States, 63110
Actively Recruiting
2
Washington Univeristy
St Louis, Missouri, United States, 63110
Actively Recruiting
Research Team
T
Tracey Bach, MBA
CONTACT
L
Laura Marks, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here